Application of IVDr NMR spectroscopy to stratify Parkinson's disease with absolute quantitation of blood serum metabolites and lipoproteins.
Berezhnoy G, Bae G, Wüst L, Schulte C, Cannet C, Wurster I, Zimmermann M, Jäck A, Spruth EJ, Hellmann-Regen J, Roeske S, Pürner D, Glanz W, Maass F, Hufschmidt F, Kilimann I, Dinter E, Kimmich O, Gamez A, Levin J, Priller J, Peters O, Wagner M, Storch A, Lingor P, Düzel E, van Riesen C, Wüllner U, Teipel S, Falkenburger B, Bähr M, Zerr I, Petzold GC, Spottke A, Rizzu P, Brosseron F, Schäfer H, Gasser T, Trautwein C.
Berezhnoy G, et al.
Sci Rep. 2025 May 22;15(1):17738. doi: 10.1038/s41598-025-01352-0.
Sci Rep. 2025.
PMID: 40404791
Free article.
The challenge of early detection and stratification in Parkinson's disease (PD) is urgent due to the current emergence of mechanism-based disease-modifying treatments. ...Uni- and multivariate statistics were used to identify metabolism-driven changes …
The challenge of early detection and stratification in Parkinson's disease (PD) is urgent due to the current emergence …